Abstract

Hypoxia is one of the main insults in proliferative retinopathies, leading to neovascularization and neurodegeneration. To maintain homeostasis, neurons require efficient degradation and recycling systems. Autophagy participates in retinal cell death, but it is also a cell survival mechanism. Here, we analyzed the role of autophagy at the three characteristic time periods in the oxygen-induced retinopathy (OIR) mouse model and determined if its modulation can improve vascular and non-vascular alterations. Experiments were performed with chloroquine (CQ) in order to monitor autophagosome accumulation by lysosomal blockade. Post natal day (P)17 OIR mouse retinas showed a significant increase in autophagy flux. In particular, an intense LC3B and p62 staining was observed in inner layers of the retina, mainly proliferating endothelial cells. After a single intraocular injection of Rapamycin at P12 OIR, a decreased neovascular area and vascular endothelial growth factor (VEGF) protein expression were observed at P17 OIR. In addition, whereas the increased expression of glial fibrillary acidic protein (GFAP) was reversed at P26 OIR, the functional alterations persisted. Using a similar therapeutic schedule, we analyzed the effect of anti-VEGF therapy on autophagy flux. Like Rapamycin, VEGF inhibitor treatment not only reduced the amount of neovascular tufts, but also activated autophagy flux at P17 OIR, mainly in ganglion cell layer and inner nuclear layer. Finally, the effects of the disruption of autophagy by Spautin-1, were evaluated at vascular, glial, and neuronal levels. After a single dose of Spautin-1, Western blot analysis showed a significant decrease in LC3B II and p62 protein expression at P13 OIR, returning both autophagy markers to OIR control levels at P17. In addition, neither gliosis nor functional alterations were attenuated. In line with these results, TUNEL staining showed a slight increase in the number of positive cells in the outer nuclear layer at P17 OIR. Overall, our results demonstrate that all treatments of induction or inhibition of the autophagic flux reduced neovascular area but were unable to completely reverse the neuronal damage. Besides, compared to current treatments, rapamycin provides a more promising therapeutic strategy as it reduces both neovascular tufts and persistent gliosis.

Highlights

  • Retinal neovascular pathologies are still leading causes of blindness worldwide in middle age (DR) and pediatric [retinopathy of prematurity (ROP)] population (Campochiaro, 2015; Rubio and Adamis, 2016)

  • Quantitative analysis revealed a slight increase in microtubule-associated proteins 1A/1B light chain 3B (LC3B) II protein expression level at P12 in oxygen-induced retinopathy (OIR) mice, which was markedly upregulated in P17, returning to baseline levels at P26

  • Quantitative analysis showed an increase, not statistically significant, in both LC3B II and p62 levels at P17 OIR compared to room air (RA) mice retinas injected with vehicle, which were further enhanced after CQ treatment (Figure 1F)

Read more

Summary

Introduction

Retinal neovascular pathologies are still leading causes of blindness worldwide in middle age (DR) and pediatric [retinopathy of prematurity (ROP)] population (Campochiaro, 2015; Rubio and Adamis, 2016). Vascular endothelial growth factor is one of the most critical target genes of HIF, and a well-known key player in neovascularization (NV) (Nagy et al, 2008). This trophic factor has pleiotropic functions over neurons and ECs in health and disease (Saint-Geniez et al, 2008; Zhang et al, 2009). Anti-VEGF treatment has shown better outcomes than alternative treatments, ophthalmologists have detected unequal response of patients to the same administration scheme. They have observed that some patients lost visual acuity after the chronic treatment (Osaadon et al, 2014; Yang et al, 2016). VEGF is a neuroprotective factor and its further depletion has deleterious effects over neuronal survival

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call